Skip to main content
TipRanks
Go Ultimate75% OFF

Molecular Partners AG (MLLCF) Stock Statistics & Valuation Metrics

10 Followers

Total Valuation

Molecular Partners AG has a market cap or net worth of $112.91M. The enterprise value is $55.01M.

Market Cap
$112.91M
Enterprise Value
$55.01M

Share Statistics

Molecular Partners AG has 40,374,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
40,374,640
Owned by Insiders
―
Owned by Institutions
0.63%

Financial Efficiency

Molecular Partners AG’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -60.07%.

Return on Equity (ROE)
-0.77
Return on Assets (ROA)
-0.60
Return on Invested Capital (ROIC)
-60.07%
Return on Capital Employed (ROCE)
-0.61
Revenue Per Employee
0
Profits Per Employee
-460.08K
Employee Count
134
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Molecular Partners AG is -1.74. Molecular Partners AG’s PEG ratio is -0.10.

PE Ratio
-1.74
PS Ratio
0.00
PB Ratio
1.78
Price to FCF
-1.95
Price to Operating Cash Flow
-1.96
PEG Ratio
-0.10

Income Statement

In the last 12 months, Molecular Partners AG had revenue of 0 and earned -61.65M in profits. Earnings per share was -1.65.

Revenue
0
Gross Profit
-2.15M
Operating Income
-55.44M
Pretax Income
-61.65M
Net Income
-61.65M
EBITDA
-53.29M
Earnings Per Share (EPS)
-1.65

Cash Flow

In the last 12 months, operating cash flow was -46.04M and capital expenditures -159,000, giving a free cash flow of -46.20M billion.

Operating Cash Flow
-46.04M
Free Cash Flow
-46.20M
Free Cash Flow per Share
-1.21

Dividends & Yields

Molecular Partners AG pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-53.80%
Earnings Yield
-59.53%

Stock Price Statistics

Beta
0.63
52-Week Price Change
11.39%
50-Day Moving Average
4.01
200-Day Moving Average
3.40
Relative Strength Index (RSI)
87.46
Average Volume (3m)
5,100

Important Dates

Molecular Partners AG upcoming earnings date is Mar 05, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 25, 2026
Next Earnings Date
Mar 05, 2027
Ex-Dividend Date
―

Financial Position

Molecular Partners AG as a current ratio of 8.79, with Debt / Equity ratio of 4.54%

Current Ratio
8.79
Quick Ratio
8.79
Debt to Market Cap
0.00
Net Debt to EBITDA
1.48
Interest Coverage Ratio
-15.84

Taxes

In the past 12 months, Molecular Partners AG has paid 2,000 in taxes.

Income Tax
2,000
Effective Tax Rate
-0.00

Enterprise Valuation

Molecular Partners AG EV to EBITDA ratio is -0.63, with an EV/FCF ratio of -0.67.

EV to Sales
0.00
EV to EBITDA
-0.63
EV to Free Cash Flow
-0.67
EV to Operating Cash Flow
-0.68

Balance Sheet

Molecular Partners AG has $57.49M in cash and marketable securities with $2.74M in debt, giving a net cash position of $54.75M billion.

Cash & Marketable Securities
$57.49M
Total Debt
$2.74M
Net Cash
$54.75M
Net Cash Per Share
$1.36
Tangible Book Value Per Share
$1.32

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Molecular Partners AG is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
11.22%